Watchers | 11,452 |
52-Wk Low | $0.142 |
52-Wk High | $11.65 |
Market Cap | $0.00 |
Volume | 11.37M |
52-Wk High | $11.65 |
52-Wk Low | $0.142 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Insys Therapeutics, Inc. market cap is N/A.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Insys Therapeutics, Inc. 52 week high is $11.65 as of May 11, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Insys Therapeutics, Inc. 52 week low is $0.142 as of May 11, 2024.
Insys Therapeutics, Inc. stock price today is $0.2911.
Insys Therapeutics, Inc. stock price yesterday was $0.2951.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Insys Therapeutics, Inc.’s P/E ratio is None.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Insys Therapeutics, Inc. P/B ratio is None.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Insys Therapeutics, Inc.'s EBITDA is -2.08.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Insys Therapeutics, Inc. 50-day moving average is $2.05.
Insys Therapeutics, Inc. has 226 employees.